Informed Consent for Therapy and Research in Continuous Renal Replacement Therapy: An International Survey

Author:

Zamperetti N.1,Bellomo R.2,Ronco C.3,Bolgan I.3,Ricci Z.3

Affiliation:

1. Department of Anaesthesia and Intensive Care Medicine, San Bortolo Hospital, Vicenza - Italy

2. Department of Intensive Care, Austin & Repatriation Medical Center, Heidelberg, Victoria - Australia

3. Department of Nephrology, San Bortolo Hospital, Vicenza - Italy

Abstract

Objective To study the approach of health care workers (HCW) to informed consent for therapy and research in the field of continuous renal replacement therapy (CRRT) Design Administration of questionnaire. Setting Two International Courses on Critical Care Nephrology (CCN) held in Vicenza and Melbourne. Participants Eight hundred and twenty one course participants. Results We obtained 349 analysable questionnaires (42.5% of participants). Only 22.5% of responders always obtain informed consent for CRRT; 70.3% just inform patients/relatives without seeking consent, 7.1% never obtain informed consent. In ICU patients, informed consent is considered “good, correct and feasible” for therapy and for research by only 13% and 27% of responders, respectively. Consent for clinical research obtained from the next of kin or legal guardian is considered “good, correct and feasible” by 56.3% of respondents, while 39.1% believe that next of kin or legal guardians can not really make informed decisions. Finally, nearly half of responders think that present rules hamper research in ICU. For many questions, significant variability of responses was found according to profession, speciality and origin of responders. Conclusions In the field of CRRT, stated practice, beliefs and currently accepted ethical standards vary greatly according to profession, speciality and origin. A significant disagreement between what is widely promoted to be the “correct” approach and what is currently done is evident.

Publisher

SAGE Publications

Subject

Biomedical Engineering,Biomaterials,General Medicine,Medicine (miscellaneous),Bioengineering

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3